oalib

OALib Journal期刊

ISSN: 2333-9721

费用：99美元

投稿

时间不限

( 2672 )

( 2024 )

( 2023 )

( 2022 )

自定义范围…

匹配条件： “ Taufig AZ” ，找到相关结果约13338条。
列表显示的所有文章，均可免费获取
第1页/共13338条
每页显示 条
Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice
Prager W,Huber-Vorländer J,Taufig AZ,Imhof M
Clinical, Cosmetic and Investigational Dermatology , 2012,
Abstract: Welf Prager,1 Jürgen Huber-Vorl nder,2 A Ziah Taufig,3 Matthias Imhof,4 Ulrich Kühne,4 Ruth Weissberg,5 Lars-Peter Kuhr,6 Volker Rippmann,3 Wolfgang G Philipp-Dormston,7 Thomas M Proebstle,8 Claudia Roth,9 Martina Kerscher,10 Claudius Ulmann,11 Tatjana Pavicic121Dermatologikum, Hamburg, 2Fort Malakoff Klinik, Mainz, 3Praxisklinik für Plastische und sthetische Chirurgie, Cologne, 4 sthetische Dermatologie im Medico Palais, Bad Soden, 5Taimerhofstrasse 28, Munich, 6Aqua Medical Spa, Munich; 7Hautzentrum K ln, Cologne, 8Privatklinik Proebstle GmbH, Mannheim, 9K -Klinik, Düsseldorf, 10MIN Fakult t/Department Chemie/Kosmetikwissenschaft, Hamburg, 11Kosmas Klinik, Bad Neuenahr-Ahrweiler, 12Klinik und Poliklinik für Dermatologie und Allergologie, Munich, GermanyBackground: Botulinum toxin type A treatment has been used for over 20 years to enhance the appearance of the face. There are several commercially available botulinum toxin type A products used in aesthetic clinical practice. The aim of this retrospective analysis was to compare the clinical efficacy of the most commonly used botulinum toxin type A preparations in daily practice.Methods: Physicians from 21 centers in Germany completed questionnaires based on an inspection of subject files for subjects 18 years of age or over who had received at least two, but not more than three, consecutive treatments with incobotulinumtoxinA, onabotulinumtoxinA, or abobotulinumtoxinA within a 12-month period in the previous 2 years. Data on subject and physician satisfaction, treatment intervals, dosages, and safety were collected from 1256 subjects.Results: There were no statistically significant differences between incobotulinumtoxinA and onabotulinumtoxinA with respect to physician and subject satisfaction, dosages, and adverse effects experienced. Both botulinum toxin type A preparations were well tolerated and effective in the treatment of upper facial lines. Due to low treatment numbers, abobotulinumtoxinA was not included in the statistical analysis.Conclusion: The results of this retrospective analysis confirm the results of prospective clinical trials by demonstrating that, in daily practice, incobotulinumtoxinA and onabotulinumtoxinA are used at a 1:1 dose ratio and display comparable efficacy and safety.Keywords: NT 201, incobotulinumtoxinA, onabotulinumtoxinA, abobotulinumtoxinA, upper face, retrospective analysis
Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice
Prager W, Huber-Vorl nder J, Taufig AZ, Imhof M, Kühne U, Weissberg R, Kuhr LP, Rippmann V, Philipp-Dormston WG, Proebstle TM, Roth C, Kerscher M, Ulmann C, Pavicic T
Clinical, Cosmetic and Investigational Dermatology , 2012, DOI: http://dx.doi.org/10.2147/CCID.S26550
Abstract: otulinum toxin type A treatment to the upper face: retrospective analysis of daily practice Review (2441) Total Article Views Authors: Prager W, Huber-Vorl nder J, Taufig AZ, Imhof M, Kühne U, Weissberg R, Kuhr LP, Rippmann V, Philipp-Dormston WG, Proebstle TM, Roth C, Kerscher M, Ulmann C, Pavicic T Published Date June 2012 Volume 2012:5 Pages 53 - 58 DOI: http://dx.doi.org/10.2147/CCID.S26550 Received: 29 February 2012 Accepted: 10 April 2012 Published: 11 June 2012 Welf Prager,1 Jürgen Huber-Vorl nder,2 A Ziah Taufig,3 Matthias Imhof,4 Ulrich Kühne,4 Ruth Weissberg,5 Lars-Peter Kuhr,6 Volker Rippmann,3 Wolfgang G Philipp-Dormston,7 Thomas M Proebstle,8 Claudia Roth,9 Martina Kerscher,10 Claudius Ulmann,11 Tatjana Pavicic12 1Dermatologikum, Hamburg, 2Fort Malakoff Klinik, Mainz, 3Praxisklinik für Plastische und sthetische Chirurgie, Cologne, 4 sthetische Dermatologie im Medico Palais, Bad Soden, 5Taimerhofstrasse 28, Munich, 6Aqua Medical Spa, Munich; 7Hautzentrum K ln, Cologne, 8Privatklinik Proebstle GmbH, Mannheim, 9K -Klinik, Düsseldorf, 10MIN Fakult t/Department Chemie/Kosmetikwissenschaft, Hamburg, 11Kosmas Klinik, Bad Neuenahr-Ahrweiler, 12Klinik und Poliklinik für Dermatologie und Allergologie, Munich, Germany Background: Botulinum toxin type A treatment has been used for over 20 years to enhance the appearance of the face. There are several commercially available botulinum toxin type A products used in aesthetic clinical practice. The aim of this retrospective analysis was to compare the clinical efficacy of the most commonly used botulinum toxin type A preparations in daily practice. Methods: Physicians from 21 centers in Germany completed questionnaires based on an inspection of subject files for subjects 18 years of age or over who had received at least two, but not more than three, consecutive treatments with incobotulinumtoxinA, onabotulinumtoxinA, or abobotulinumtoxinA within a 12-month period in the previous 2 years. Data on subject and physician satisfaction, treatment intervals, dosages, and safety were collected from 1256 subjects. Results: There were no statistically significant differences between incobotulinumtoxinA and onabotulinumtoxinA with respect to physician and subject satisfaction, dosages, and adverse effects experienced. Both botulinum toxin type A preparations were well tolerated and effective in the treatment of upper facial lines. Due to low treatment numbers, abobotulinumtoxinA was not included in the statistical analysis. Conclusion: The results of this retrospective analysis confirm the results of prospective clinical trials by demonstrating that, in daily practice, incobotulinumtoxinA and onabotulinumtoxinA are used at a 1:1 dose ratio and display comparable efficacy and safety.
Pharmacist prescribing: an emerging role
Massay AZ
theHealth , 2010,
Abstract:
Apuntes sobre la aritmética Maya
Díaz Díaz,Ruy;
Educere , 2006,
Abstract: the mayan numeral system had a 20 base with 5 sub-base, positional and with use of cero. this essay ofers some algorithms for the basic arithmetic operations: addition, subtraction, multiplication and division, using the numbering system employed by the mayas. it can be noted that the reasoning used to solve the diferent operations are the same as in the arabic numbering system, with the diference that in the mayan numbers system there was no need to study multiplication tables.
Importancia de los estudios de mortalidad en diabéticos Importance of mortality studies performed in diabetics
Oscar Díaz Díaz
Revista Cubana de Endocrinología , 2001,
Abstract:
Primer consenso cubano de prediabetes First Cuban consensus of prediabetes
Oscar Díaz Díaz
Revista Cubana de Endocrinología , 2011,
Abstract:
Abstract
Oscar Díaz Díaz
Revista Cubana de Endocrinología , 2008,
Abstract:
Importancia del sitio diabetes mellitus en Infomed. Importance of the web site on diabetes mellitus in Infomed.
Oscar Díaz Díaz
Revista Cubana de Endocrinología , 2008,
Abstract:
Rese a de "Jesús María Sanromá: An American Twentieth-Century Pianist" de Alberto Hernández
Edgardo Díaz Díaz
Centro Journal , 2009,
Abstract:
Why a universe as a whole must be a quantum object  [PDF]
Pedro F. González-Díaz
Natural Science (NS) , 2011, DOI: 10.4236/ns.2011.35053
Abstract: Technical and physical reasons are given in favor of the idea that single universes, accelerating or not, essentially are quantum-mechanical entities without any classical analogs, even when they are forming part of a given multi- verse.
第1页/共13338条
每页显示 条


Home
Copyright © 2008-2020 Open Access Library. All rights reserved.